---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-271578"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:21:52.975448+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics prices $350M public offering of common stock and pre-funded warrants

## Summary
- Priced 5,317,460 shares at $63.00/share and pre-funded warrants for 238,095 shares at $62.999
- Gross proceeds expected ~$350M before expenses; funds to advance clinical pipeline and for general purposes
- Underwriters granted 30-day option to purchase up to additional 833,333 shares
- Offering expected to close Dec 6, 2024; joint book-runners: BofA, TD Cowen, Stifel, Cantor, William Blair

## SEC filing metadata
- accession: 0001193125-24-271578
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/0001193125-24-271578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/d877731d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-271578
- JSON: https://secwatch.observer/filing/0001193125-24-271578.json
- Plain text: https://secwatch.observer/filing/0001193125-24-271578.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.